Review
Copyright ©The Author(s) 2016.
World J Crit Care Med. Feb 4, 2016; 5(1): 17-26
Published online Feb 4, 2016. doi: 10.5492/wjccm.v5.i1.17
Figure 5
Figure 5 A representation of the pathology in third degree burnt skin from a patient treated with plasma-derived antithrombin and in patient without plasma-derived antithrombin treatment. Whereas the skin beneath the control eschar is dead and non-viable with clotted and coagulated blood vessels, the skin and subcutaneous tissue beneath the phAT-treated skin is more viable in comparison with fewer thrombi (personal file AKV). phAT: Plasma-derived antithrombin.